| identification and characterization of vanb2 glycopeptide resistance elements in enterococci isolated in scotland. | thirty-two vanb glycopeptide-resistant enterococci (28 enterococcus faecium and 4 enterococcus faecalis) were collected from hospitalized patients in glasgow, edinburgh, dundee, and aberdeen, scotland, and the vanb element in each was compared to vanb1 of e. faecalis strain atcc 51299. hhai digestion of pcr fragments of the vanb ligase gene was used to identify vanb subtypes. all e. faecium isolates were vanb2, and all e. faecalis isolates were vanb1. restriction fragment length polymorphism ana ... | 2000 | 10952577 |
| epidemiology and control of vancomycin-resistant enterococci (vre) in a renal unit. | this study reports an outbreak of infection and colonization caused by vancomycin-resistant enterococci (vre) in the renal service of a large teaching hospital. the polymerase chain reaction and pulsed-field gel electrophoresis were used to study the epidemiology of 26/34 strains of vancomycin-resistant enterococcus faecalis and enterococcus faecium from the outbreak in comparison with five strains from other hospitals in edinburgh and the borders, and three from other wards in the royal infirma ... | 1998 | 9819690 |
| teicoplanin monotherapy of serious infections caused by gram-positive bacteria: a re-evaluation of patients with endocarditis or staphylococcus aureus bacteraemia from a european open trial. | we have examined case records for patients who received teicoplanin alone for endocarditis or staphylococcus aureus bacteraemia. all patients with streptococcal endocarditis were cured (viridans group 14/14; group d 4/4). cure rates for other organisms were: enterococcus faecalis 3/5; s. aureus 5/10 and coagulase negative staphylococci 2/3. doses for six patients who failed because of poor response were 3.3-4.2 mg/kg. teicoplanin treatment cured 41/48 patients with s. aureus bacteraemia; treatme ... | 1991 | 1829076 |